The unmet need of iron deficiency

We deliver innovative specialty pharmaceuticals that address a significant unmet need for patients suffering from iron deficiency, with or without anemia. Our lead product ACCRUFeR® (ferric maltol) is broadly indicated for use in adults across multiple therapeutic categories.

About Us

Shield is a commercial stage specialty pharmaceutical company with a focus on addressing iron deficiency with its lead medicine ACCRUFeR®, a novel, stable, non-salt based oral therapy for adults with iron deficiency with or without anemia.

Learn more